关于 "Histone Acetyltransferases" 的结果14 个结果
- GSK-J1 lithium salt
GSK-J1 is a highly potent inhibitor of H3K27 histone demethylase JMJD3 (KDM6B) and UTX (KDM6A) with IC50 of 60 nM in cell-free assays for JMJD3 (KDM6B) , respectively, >10-fold selectivity over other tested demethylases, with IC50 of 0.95μM and 1.76μM towards JARID1B/C.
Histone Demethylases - 2,4-Pyridinedicarboxylic AcidCAS: 499-80-9
An inhibitor of 2-oxoglutarate-dependent enzymes
Histone Demethylases - JIB-04CAS: 199596-05-9
JIB-04是一种泛选择性Jumonji组蛋白去甲基化酶抑制剂,对JARID1A、JMJD2E、JMJD3、JMJD2A、JMJD2B、JMJD2C和JMJD2D的IC 50 值分别为230nM、340nM、855nM、445nM、435nM、1100nM和290nM。
- GSK J4 free baseCAS: 1373423-53-0
GSK J4 free base 是 H3K27me3/me2-去甲基化酶 JMJD3/KDM6B 和 UTX/KDM6A 的有效双重抑制剂,IC50 分别为 8.6 和 6.6 μM。 GSK J4 游离碱抑制 LPS 诱导的 TNF-α;在人原代巨噬细胞中产生,IC50 为 9 μM. GSK J4 是 GSK-J1 的细胞渗透性前药。 GSK J4 free base 诱导内质网应激相关的细胞凋亡。
Histone Demethylases - GSK J4 HClCAS: 1797983-09-5
GSK-J4 HCl 是一种小分子抑制剂,具有高效的细胞渗透性和药理学选择性抑制剂,可通过抑制 KDM6B 来保持 H3K27 甲基化。
Histone Demethylases
| 货号 | 产品名称 | CAS号 | 靶点 / 通路 | 引用 | 结构 |
|---|---|---|---|---|---|
| GC12458 | N-Oxalylglycine | 5262-39-5 | Histone Demethylases | ||
An inhibitor of JMJD2 histone demethylases | |||||
| GC17820 | AS8351 | 796-42-9 | Histone Demethylases | ||
A histone demethylase inhibitor | |||||
| GC15830 | Daminozide | 1596-84-5 | Histone Demethylases | ||
Selective inhibitor of KDM2/7 histone demethylases | |||||
| GC62678 | PFI-90 | 53995-62-3 | Histone Demethylases | ||
PFI-90 is a selective inhibitor of the histone demethylase KDM3B. PFI-90 induces apoptosis and cell differentiation resulting in delayed tumor progression in vivo. | |||||
| GC25304 | CP2 | no CAS | Histone Demethylases | ||
CP2 is a cyclic peptide that inhibits the JmjC histone demethylases KDM4 with IC50 values of 42 nM and 29 nM for KDM4A and KDM4C, respectively. | |||||
| GC36195 | GSK-J1 lithium salt | - | Histone Demethylases | ||
GSK-J1 is a highly potent inhibitor of H3K27 histone demethylase JMJD3 (KDM6B) and UTX (KDM6A) with IC50 of 60 nM in cell-free assays for JMJD3 (KDM6B) , respectively, >10-fold selectivity over other tested demethylases, with IC50 of 0.95μM and 1.76μM towards JARID1B/C. | |||||
| GC12961 | Apicidin | 183506-66-3 | Histone Demethylases | ||
A cell-permeable HDAC inhibitor | |||||
| GC11873 | 2,4-Pyridinedicarboxylic Acid | 499-80-9 | Histone Demethylases | ||
An inhibitor of 2-oxoglutarate-dependent enzymes | |||||
| GC17754 | IOX 1 | 5852-78-8 | Histone Demethylases | ||
A 2-oxoglutarate oxygenase inhibitor | |||||
| GC15603 | JIB-04 | 199596-05-9 | Other Apoptosis | ||
JIB-04是一种泛选择性Jumonji组蛋白去甲基化酶抑制剂,对JARID1A、JMJD2E、JMJD3、JMJD2A、JMJD2B、JMJD2C和JMJD2D的IC50值分别为230nM、340nM、855nM、445nM、435nM、1100nM和290nM。 | |||||
| GC12997 | GSK J4 free base | 1373423-53-0 | Histone Demethylases | ||
GSK J4 free base 是 H3K27me3/me2-去甲基化酶 JMJD3/KDM6B 和 UTX/KDM6A 的有效双重抑制剂,IC50 分别为 8.6 和 6.6 μM。 GSK J4 游离碱抑制 LPS 诱导的 TNF-α;在人原代巨噬细胞中产生,IC50 为 9 μM. GSK J4 是 GSK-J1 的细胞渗透性前药。 GSK J4 free base 诱导内质网应激相关的细胞凋亡。 | |||||
| GC10319 | TC-E 5002 | 1453071-47-0 | Histone Demethylases | ||
A KDM2/7 inhibitor | |||||
| GC10617 | GSK J1 | 1373422-53-7 | Histone Demethylases | ||
A dual inhibitor of JMJD3 and UTX | |||||
| GC15497 | GSK J4 HCl | 1797983-09-5 | Histone Demethylases | ||
GSK-J4 HCl 是一种小分子抑制剂,具有高效的细胞渗透性和药理学选择性抑制剂,可通过抑制 KDM6B 来保持 H3K27 甲基化。 | |||||
